| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1960) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C02AA02 |
| UNII: | 8B1QWR724A |
| InChI Key | QEVHRUUCFGRFIF-MDEJGZGSSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C33H40N2O9 |
| Molecular Weight | 608.69 |
| AlogP | 4.17 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 117.78 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 44.0 |
| Primary Target | |
|---|---|
| Vesicular monoamine transporter 2 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 15 | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 1600 | - | - | 100 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC18 family of vesicular amine transporters
|
- | 13 | 8 | 5-630 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 25 | |
|
Transporter
Electrochemical transporter
|
- | 7000-9200 | 8 | 5-630 | 30-85 | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 3020-3236 | - | 100 | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | 68400 | - | - | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCG subfamily
|
- | 12600-26303 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
| Atherosclerosis | 3 | D050197 | ClinicalTrials |
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Cerebrovascular Disorders | 3 | D002561 | ClinicalTrials |
| Heart Diseases | 3 | D006331 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Hypertension, Pulmonary | 1 | D006976 | ClinicalTrials |
| Amphetamine-Related Disorders | 1 | D019969 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 50-55-5 |
| ChEBI | 28487 |
| ChEMBL | CHEMBL772 |
| DrugBank | DB00206 |
| DrugCentral | 2370 |
| EPA CompTox | DTXSID7021237 |
| FDA SRS | 8B1QWR724A |
| Human Metabolome Database | HMDB0014351 |
| Guide to Pharmacology | 4823 |
| KEGG | C06539 |
| PharmGKB | PA451236 |
| PubChem | 5770 |
| SureChEMBL | SCHEMBL2589 |
| ZINC | ZINC000003938746 |